-
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
Equity healthcare
Overview ( as on 20/12/24 )
NAV
₹38.82
Last change
₹-0.22 -0.01%
Fund Size (AUM)
5024.00 Cr
Performance
30.29% (5Y)
Fund Details
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
as of 20/12/24
AUM
5024.00 Cr
Expense Ratio
1.92 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth | 49.14% | 25.88% | 30.29% |
| BSE Healthcare TR INR | 43.76% | 19.63% | 26.27% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
14.35% |
Dr Reddy's Laboratories Ltd |
9.03% |
Cipla Ltd |
8.07% |
Lupin Ltd |
4.59% |
Aurobindo Pharma Ltd |
4.57% |
Gland Pharma Ltd |
4.22% |
Apollo Hospitals Enterprise Ltd |
3.8% |
Zydus Lifesciences Ltd |
2.93% |
Divi's Laboratories Ltd |
2.69% |
Biocon Ltd |
2.39% |
Sector Allocation
Healthcare |
96.33% |
Financial |
2.5% |
Basic Materials |
1.17% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
30.29% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
29.28% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
29.28% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
27.43% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
30.74% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
27.39% (5Y)
-
